| Similar Articles |
|---|
 |
The Motley Fool
November 2, 2005
Rich Duprey |
Can Candela Regain Focus? Aesthetic laser maker reports strong gains, but can it do so consistently? It has new products, new distributors, and new markets to expand into, along with a shareholder-friendly stock buyback program.   |
The Motley Fool
February 17, 2005
Rich Duprey |
Candela Does a Slow Burn Arbitrator rules against laser maker in royalty case. Already reeling from the lackluster sales of lasers that remove varicose veins, tattoos, and the like, Candela's stock plummeted another 10%. |
The Motley Fool
August 26, 2005
Rich Duprey |
Candela Burns Holes in Logic The cosmetic laser manufacturer claims success via questionable mental gymnastics. Perhaps it ought to trim the fat off its verbiage and spare investors any more unneeded workouts. |
The Motley Fool
April 29, 2005
Rich Duprey |
Will Candela Burn Investors Again? Laser maker set to report earnings next week, but spotty record casts doubt on outcome. |
The Motley Fool
February 14, 2006
Rich Duprey |
Cutera's Laser Woes Aesthetic laser maker has a cloudy future of lower sales, earnings, and patent lawsuits. Investors, take note. |
The Motley Fool
January 17, 2007
Rich Duprey |
Foolish Forecast: Dim Hope for Candela The aesthetic-laser maker will report second-quarter 2007 financial results shortly. Investors, here what to expect. |
The Motley Fool
February 3, 2005
Rich Duprey |
Candela's Lasers Offer Dim View In the cosmetic laser maker's earnings report, it misses its estimates. Revenues, though within the range set by the company, were still at the bottom rung of the ladder at $28.2 million. |
The Motley Fool
April 30, 2007
Rich Duprey |
Foolish Forecast: Cutera Zaps Quarter Investors, don't expect the aesthetic laser maker to burn up the growth charts when it reports first-quarter results. |
The Motley Fool
April 22, 2008
Rich Duprey |
Foolish Forecast: No Sizzle at Candela In advance of earnings, analysts expect sales from aesthetic laser maker Candela to be essentially flat. |
The Motley Fool
April 17, 2007
Rich Duprey |
Foolish Forecast: A Bet Candela Can't Afford to Lose The aesthetic laser maker is set to report third-quarter 2007 financial results. Investors, here is what you can expect to see. |
The Motley Fool
April 25, 2007
Rich Duprey |
Candela's Amazing Shrinking Quarter The aesthetic laser maker reports its second consecutive quarter of declining sales. Investors, take note. |
The Motley Fool
May 3, 2006
Rich Duprey |
Candela's Cool Beam The aesthetic laser manufacturer reports steady revenues and profits. Candela's not a cheap stock at these prices, even with the sell-off. |
The Motley Fool
October 26, 2006
Rich Duprey |
Candela's October Surprise The aesthetic laser maker trounces analyst projections, though all may not be what it seems. Investors, take note. |
The Motley Fool
April 24, 2008
Rich Duprey |
Candela Fizzles Aesthetic laser maker Candela reports slightly higher revenue but wider-than-anticipated losses. |
The Motley Fool
February 1, 2006
Rich Duprey |
Candela Is Finally White Hot The aesthetic laser maker finally produces the white-hot sales growth it promised -- two years ago. In midday trading, the stock soared 30%. |
The Motley Fool
August 18, 2006
Rich Duprey |
Candela Singed by Patent Lawsuit The cosmetic laser maker, hit by rival's claim of infringement, fires back with a counterclaim. Investors, with Candela releasing its earnings report next week, this is sure to be a white hot topic on the conference call. Investors, take note. |
The Motley Fool
May 8, 2007
Rich Duprey |
Cutera's Ugly Quarter The aesthetic laser maker's weak domestic sales dim the outlook for the rest of the year. Investors, take note. |
The Motley Fool
April 3, 2007
Rich Duprey |
Palomar Medical Burns Another Rival The aesthetic laser maker zaps a privately held firm for patent infringement. But one company not buckling under to Palomar's aggressive tactics is Candela. Investors, take note. |
The Motley Fool
January 31, 2008
Rich Duprey |
Candela Investors Burned Again The aesthetic-laser maker continues its string of disappointing quarters. |
The Motley Fool
September 10, 2007
Rich Duprey |
A Strategic Alternative for Candela In an SEC filing, hedge fund Third Point LLC reports its discussions of "strategic alternatives" at laser maker Candela. Some say a sale was discussed. Investors should take notice. |
The Motley Fool
April 10, 2007
Rich Duprey |
The Beauty of Lasers With aesthetic laser treatments booming, which company looks the best? Candela... Cutera... Palomar Medical Technologies... Cynosure... Syneron... |
The Motley Fool
January 24, 2007
Rich Duprey |
Candela's Number Is Up The aesthetic laser maker reports dismal results that fall short of its own fuzzy math expectations. |
The Motley Fool
August 28, 2007
Rich Duprey |
Candela's Chance to Fan the Flames The maker of lasers used in aesthetic procedures receives FDA approval for an innovative pain reduction technology. Investors, it needs something. Sales have been giving off a pretty weak signal lately, and management admits it has been losing market share. |
The Motley Fool
August 22, 2006
Rich Duprey |
Candela Goes Dark Atop recent legal woes, the laser maker reports gloomy quarterly earnings. Investors, take note. |
The Motley Fool
March 15, 2007
Rich Duprey |
Candela Eases the Pain The aesthetic laser maker acquires an innovative technology that minimizes pain. Investors, it's essentially an investment in the future, but one that still entails some risk. |
The Motley Fool
May 22, 2006
Rich Duprey |
A Change of Heart for Candela An upgrade of the laser maker points out the futility of watching analysts' shifting opinions. One of the tricks to generating long-term profits is to ignore the shifting winds of analyst sentiment and focus solely on the ability of the company to deliver. |
The Motley Fool
November 5, 2004
Rich Duprey |
Profit From Management Integrity Laser manufacturer Candela's management avoids taking the easy way out to explain shortfalls. It's a sign of management integrity that will lead to future profits. |
The Motley Fool
April 7, 2008
Rich Duprey |
No Class Act at Candela A class action lawsuit could burn the aesthetic-laser maker. |
The Motley Fool
May 2, 2007
Rich Duprey |
Cynosure Sure Looks Good Aesthetic-laser maker reports record results on strength of new laser offerings. Investors, take note. |
The Motley Fool
January 10, 2006
Rich Duprey |
Biolase Brightens Outlook The aesthetic laser company expects to be cash flow-neutral on flat revenues. Investors cheer. |
The Motley Fool
March 14, 2008
Rich Duprey |
No Point Man at Candela Activist hedge fund Third Point cuts its stake in the aesthetic laser maker Candela from 9% to only 3.5%. |
The Motley Fool
September 19, 2005
Rich Duprey |
Candela's Beam Not So Hot The laser maker delays filing its annual report as it searches for material weaknesses. Delays in filing its annual reports are head-shaking distractions to performance that investors just don't need. |
The Motley Fool
September 12, 2006
Rich Duprey |
A Fuzzy Forecast for Candela Based on company-specific trends, the balance of 2006 will be a bust for the aesthetic laser maker. Investors, take note. |
The Motley Fool
May 9, 2007
Rich Duprey |
BioLase's Dull Quarter The dental laser maker makes good on its promise of a disappointing quarter, but the future may be bright for investors. |
The Motley Fool
February 13, 2007
Rich Duprey |
Palomar's Parallax View A plethora of one-time revenues skewed the aesthetic laser maker's results. Investors, take note. |
The Motley Fool
February 11, 2005
Stephen D. Simpson |
Laser Beamer Lookin' Good Palomar continues to build a profitable business in the highly competitive cosmetic laser market. |
The Motley Fool
April 9, 2007
Rich Duprey |
Cutera's Meltdown The maker of aesthetic lasers lowers guidance, and Mr. Market's reaction isn't surprising. |
The Motley Fool
February 13, 2006
Stephen D. Simpson |
Will Syneron Defy History? Publicly traded laser companies have a legacy of failure; will Syneron manage to turn that tide? |
The Motley Fool
May 12, 2006
Rich Duprey |
Cutera Continues to Burn The aesthetic laser maker is at risk of losing a patent lawsuit against a competitor. Investors, patents by themselves should not be considered a sufficient competitive moat to induce investment in a company. |
The Motley Fool
April 17, 2007
Rich Duprey |
BioLase Darkens Smiles The dental laser maker warns that quarterly revenues will be dramatically lower. Investors, take note. |
The Motley Fool
August 22, 2007
Rich Duprey |
A Weak Signal at Candela The aesthetic-laser maker continues to show declining sales and earnings. Investors, take note. |
The Motley Fool
March 24, 2006
Rich Duprey |
Honing In on Laserscope The medical-use laser manufacturer may get a boost from a laser deal with China. Investors, one deal does not a quarter make, but it could be signal that the tide is turning for this leading medical device laser manufacturer. |
The Motley Fool
May 15, 2006
Stephen D. Simpson |
Sales and Marketing Slam Syneron Higher expenses and disappointing results leave the med-tech stock suffering. |
The Motley Fool
October 5, 2005
Rich Duprey |
Candela's Options Zap Profits The aesthetic laser-maker will capitalize on an accounting rule to accelerate options vesting. The company is basing its decisions not on what's best for business, but on how to make the accounting look good. That should give investors a lot to think about. |
The Motley Fool
November 11, 2008
Brian Orelli |
Two Years of Red Aesthetic laser makers have been rocked over the last few years. |
The Motley Fool
December 17, 2008
Rick Aristotle Munarriz |
5 More Stocks on Wall Street's Dollar Menu Four quarters for a public company? These five stocks take that statement literally. Take a look at: Candela Laser... Sanmina-SCI... Stein Mart... RF Micro Devices... Jamba... |
The Motley Fool
July 27, 2011 |
Palomar Medical Technologies Earnings Preview Palomar Medical Technologies will unveil its latest earnings Thursday. |
The Motley Fool
September 27, 2007
Brian D. Pacampara |
5 More Turnaround Stocks These companies may be poised for turnarounds: Alberto-Culver, ACI Worldwide, Palomar Medical Technologies, Carter's, and Aspreva Pharmaceuticals. Investors should consider, but with caution. |
The Motley Fool
July 20, 2004
Rich Duprey |
Lasers Lose Focus Dental-equipment manufacturer Biolase reports flat sales. |
The Motley Fool
May 15, 2008
Brian Orelli |
So-So Syneron A little growth is an acceptable outcome in the struggling medical laser industry. |
